Newsfeeds - Spark Newswire

1 minute read

Earnings

Earnings Preview: Processa Pharmaceuticals

Today, 3:26 PM

Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Processa Pharmaceuticals will report an earnings per share (EPS) of $-0.34.

PCSA

1 minute read

FDA
News

Processa Says Successfully Identifies Next Generation Capecitabine Dosage Regimens For Phase 2B Trial

By Benzinga Newsdesk

Today, 3:26 PM

Next Generation Capecitabine (NGC) Dosage Regimens Have Been Identified In The Ongoing Phase

PCSA

5 minute read

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:26 PM

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS

4 minute read

Processa Pharmaceuticals Provides Update On Enrollment Across All Clinical Programs

By Benzinga Newsdesk

Today, 3:26 PM

PCS12852 for Gastroparesis concluded enrollment a month ahead of schedule. Statistics on gastric emptying, safety and GEBT data will be available by the end of October and full topline data is expected before year

PCSA

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 3:26 PM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG